{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:25:40Z","timestamp":1783441540801,"version":"3.54.6"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Remnant cholesterol (RC) has been recognized as a critical risk factor for vascular diseases. However, its association with cardiovascular disease (CVD) and overall mortality in individuals with diabetic kidney disease (DKD) has not been thoroughly investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center study enrolled 329 patients with biopsy-confirmed DKD from August 2009 to December 2018. The prognosis of patients with varying RC levels was compared. In addition, the association between RC levels and left ventricular structure and function was examined. Furthermore, the predictive capability of RC for clinical outcomes was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over the follow-up period, 76 patients (23.1%) experienced CVD events, while 44 patients (13.4%) died. Kaplan-Meier analysis demonstrated that patients in the high RC group exhibited significantly elevated rates of CVD events (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0047) and all-cause mortality (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0213). Additionally, multivariate Cox regression analysis confirmed RC as an independent risk factor for CVD events (HR = 1.323, 95% CI 1.076-1.626,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008) and overall mortality (HR = 1.359, 95% CI 1.039-1.779,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.025). Finally, the AUC analysis indicated that the inclusion of RC in traditional risk factors improved their predictive accuracy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RC independently contributes to the risk of CVD events and all-cause mortality in individuals with biopsy-confirmed DKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1720189","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:46:07Z","timestamp":1769582767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of remnant cholesterol with cardiovascular events and mortality in biopsy-proven diabetic kidney disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Qiyuan","family":"Hu","sequence":"first","affiliation":[{"name":"The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[{"name":"The Center of Experimental Teaching Management, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Xing","sequence":"additional","affiliation":[{"name":"Faculty of Pediatrics, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Xu","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachuan","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University)","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewu","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chongqing University Three Gorges Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: A report of US and global data from the American heart association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Marx-Sch\u00fctt","year":"2025","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e191540","DOI":"10.1001\/jamanetworkopen.2019.1540","article-title":"Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic Asian population","volume":"2","author":"Sabanayagam","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.071079","article-title":"Albuminuria in cardiovascular, kidney, and metabolic disorders: A state-of-the-art review","volume":"151","author":"Claudel","year":"2025","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.2924","article-title":"Association of empagliflozin treatment with albuminuria levels in patients with heart failure: A secondary analysis of EMPEROR-pooled","volume":"7","author":"Ferreira","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.123.321752","article-title":"Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease","volume":"132","author":"Baaten","year":"2023","journal-title":"Circ Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: A consensus report by the American diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","year":"2020","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.070039","article-title":"Relationship Between renin, aldosterone, aldosterone-to-renin ratio and arterial stiffness and left ventricular mass index in young adults","volume":"150","author":"Ananda","year":"2024","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.124.325488","article-title":"Renal-cardiac crosstalk in the pathogenesis and progression of heart failure","volume":"136","author":"Noels","year":"2025","journal-title":"Circ Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/CIRCRESAHA.123.324001","article-title":"Cardiovascular consequences of uremic metabolites: an overview of the involved signaling pathways","volume":"134","author":"Curaj","year":"2024","journal-title":"Circ Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13040455","article-title":"Oxidative stress: A culprit in the progression of diabetic kidney disease","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxid (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: A presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046783","article-title":"Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings","volume":"142","author":"Wright","year":"2020","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.310269","article-title":"Nonfasting triglycerides, low-density lipoprotein cholesterol, and heart failure risk: two cohort studies of 113\u2009554 individuals","volume":"38","author":"Varbo","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000125278.58527.F3","article-title":"Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype","volume":"109","author":"Twickler","year":"2004","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061774","article-title":"Triglyceride-rich lipoproteins and their remnants as silent promoters of atherosclerotic cardiovascular disease and other metabolic disorders: A review","volume":"13","author":"Sasc\u0103u","year":"2021","journal-title":"Nutrients"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e148559","DOI":"10.1172\/JCI148559","article-title":"Addressing dyslipidemic risk beyond LDL-cholesterol","volume":"132","author":"Tall","year":"2022","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"J\u00f8rgensen","year":"2013","journal-title":"Eur Heart J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.10.029","article-title":"Remnant cholesterol and atherosclerotic cardiovascular disease risk","volume":"76","author":"Burnett","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12933-022-01667-6","article-title":"Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study","volume":"21","author":"Huh","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13298","article-title":"Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes","volume":"290","author":"Jansson Sigfrids","year":"2021","journal-title":"J Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e015589","DOI":"10.1161\/CIRCIMAGING.123.015589","article-title":"Remnant cholesterol in young adulthood is associated with left ventricular remodeling and dysfunction in middle age: the CARDIA study","volume":"16","author":"Xu","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2005.05.002","article-title":"Plasma triglyceride level is an independent predictor of altered left ventricular relaxation","volume":"18","author":"de las Fuentes","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac822","article-title":"Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality","volume":"44","author":"Wadstr\u00f6m","year":"2023","journal-title":"Eur Heart J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.004426","article-title":"Association of aortic stiffness with left ventricular remodeling and reduced left ventricular function measured by magnetic resonance imaging: the multi-ethnic study of atherosclerosis","volume":"9","author":"Ohyama","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa172","article-title":"Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study","volume":"41","author":"Kaltoft","year":"2020","journal-title":"Eur Heart J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02081-2","article-title":"Remnant cholesterol and the risk of aortic valve calcium progression: insights from the MESA study","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"zwaf037","DOI":"10.1093\/eurjpc\/zwaf037","article-title":"The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study","volume":"6","author":"Kraaijenhof","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab432","article-title":"Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study","volume":"42","author":"Quispe","year":"2021","journal-title":"Eur Heart J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab533","article-title":"Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and incident diabetic nephropathy","volume":"106","author":"Yu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100774","article-title":"Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study","volume":"36","author":"Hansen","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.124.321387","article-title":"Impaired renal function with higher remnant cholesterol related to risk of atherosclerotic cardiovascular disease: A cohort study","volume":"44","author":"El\u00edas-L\u00f3pez","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111639","article-title":"Remnant cholesterol is an independent risk factor for the incidence of chronic kidney disease in newly-diagnosed type 2 diabetes: A nationwide population-based study","volume":"210","author":"Jang","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1331603","article-title":"Association of remnant cholesterol with renal function and its progression in patients with type 2 diabetes related chronic kidney disease","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16258","article-title":"Association between remnant cholesterol and chronic kidney disease: Systematic review and meta-analysis","volume":"27","author":"Karakasis","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: A report of the american college of cardiology solution set oversight committee","volume":"78","author":"Virani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Das Pradhan","year":"2022","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae090","article-title":"Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial","volume":"31","author":"Zimerman","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2402309","article-title":"Olezarsen for hypertriglyceridemia in patients at high cardiovascular risk","volume":"390","author":"Bergmark","year":"2024","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.060","article-title":"Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review","volume":"75","author":"Cho","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9150(00)00484-6","article-title":"Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study","volume":"154","author":"McNamara","year":"2001","journal-title":"Atherosclerosis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e005562","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex differences in the use of statins in community practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2023.02.009","article-title":"Remnant cholesterol as a risk factor for all-cause and cardiovascular mortality in incident peritoneal dialysis patients","volume":"33","author":"Deng","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1373\/clinchem.2015.253757","article-title":"Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease","volume":"62","author":"Jepsen","year":"2016","journal-title":"Clin Chem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1720189\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:46:08Z","timestamp":1769582768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1720189\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":54,"alternative-id":["10.3389\/fendo.2026.1720189"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1720189","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"1720189"}}